Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02735356 · ClinicalTrials.gov registry record · Early Phase 1
Topical Itraconazole in Treating Patients With Basal Cell Cancer
A Early Phase 1 study, sponsored by Jean Yuh Tang.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 9
- Enrollment target
NCT02735356 is a Early Phase 1 study that has completed, run by Jean Yuh Tang. The registered enrollment target is 9 participants.
The verdict
NCT02735356, a Early Phase 1 study, has completed, sponsored by Jean Yuh Tang.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 9 participants
- Enrollment target
Study Summary
This phase 0 trial studies how well itraconazole gel works in treating patients with basal cell cancer. Itraconazole gel may help to treat basal cell tumors in patients.
Interventions
- OTHER Placebo
- DRUG Itraconazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2016-05-05 |
| Est. Completion | 2017-10-10 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02735356
The ClinicalTrials.gov registry entry for NCT02735356 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jean Yuh Tang, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02735356 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02735356 about?
NCT02735356 is a clinical study titled "Topical Itraconazole in Treating Patients With Basal Cell Cancer". This phase 0 trial studies how well itraconazole gel works in treating patients with basal cell cancer. Itraconazole gel may help to treat basal cell tumors in patients.
What is the current status of trial NCT02735356?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 9 participants. The study started on 2016-05-05. Estimated completion is 2017-10-10.
What interventions are being tested in trial NCT02735356?
The interventions under investigation include: Placebo (OTHER), Itraconazole (DRUG).
Who is sponsoring clinical trial NCT02735356?
This trial is sponsored by Jean Yuh Tang, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.